192 related articles for article (PubMed ID: 15925998)
1. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.
Küker W; Nägele T; Korfel A; Heckl S; Thiel E; Bamberg M; Weller M; Herrlinger U
J Neurooncol; 2005 Apr; 72(2):169-77. PubMed ID: 15925998
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic impact of preoperative corticosteroids in primary central nervous system lymphoma.
Bullis CL; Maldonado-Perez A; Bowden SG; Yaghi N; Munger D; Wood MD; Barajas RF; Ambady P; Neuwelt EA; Han SJ
J Clin Neurosci; 2020 Feb; 72():287-291. PubMed ID: 31648968
[TBL] [Abstract][Full Text] [Related]
3. The Utility of Multiparametric Magnetic Resonance Imaging in Reducing Diagnostic Uncertainty for Primary Central Nervous System Lymphoma.
Goel A; Flintham R; Pohl U; Nagaraju S; Meade S; Sanghera P; Benghiat H; Ughratdar I; Wykes V; Sawlani V
World Neurosurg; 2024 May; ():. PubMed ID: 38740086
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.
Schulz N; Nichelli L; Schenone L; Ursu R; Abraham J; Le Cann M; Morel V; Boussen I; Herran D; Leclercq D; Blonski M; Mathon B; Hoang-Xuan K; Soussain C; Choquet S; Houillier C
J Neurooncol; 2024 Jun; ():. PubMed ID: 38865013
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging.
Haldorsen IS; Espeland A; Larsson EM
AJNR Am J Neuroradiol; 2011; 32(6):984-92. PubMed ID: 20616176
[TBL] [Abstract][Full Text] [Related]
6. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
7. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.
Haldorsen IS; Kråkenes J; Krossnes BK; Mella O; Espeland A
AJNR Am J Neuroradiol; 2009 Apr; 30(4):744-51. PubMed ID: 19164442
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
[TBL] [Abstract][Full Text] [Related]
9. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
10. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
Zacharia TT; Law M; Naidich TP; Leeds NE
J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma.
Barajas RF; Rubenstein JL; Chang JS; Hwang J; Cha S
AJNR Am J Neuroradiol; 2010 Jan; 31(1):60-6. PubMed ID: 19729544
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
15. Imaging of primary central nervous system lymphoma.
Tang YZ; Booth TC; Bhogal P; Malhotra A; Wilhelm T
Clin Radiol; 2011 Aug; 66(8):768-77. PubMed ID: 21513925
[TBL] [Abstract][Full Text] [Related]
16. An atypical presentation of primary central nervous system lymphoma: A case report.
Yuen CA; Mastrianni J; Ali S; Pytel P; Park DM; Rezania K
Medicine (Baltimore); 2020 Sep; 99(38):e22062. PubMed ID: 32957327
[TBL] [Abstract][Full Text] [Related]
17. Atypical presentation of primary central nervous system non-Hodgkin lymphoma in immunocompetent young adults.
Cheatle JT; Aizenberg MR; Weinberg JS; Surdell DL
World Neurosurg; 2013; 79(3-4):593.e9-13. PubMed ID: 22885166
[TBL] [Abstract][Full Text] [Related]
18. Primary central nervous system lymphoma: presentation, diagnosis and staging.
Eichler AF; Batchelor TT
Neurosurg Focus; 2006 Nov; 21(5):E15. PubMed ID: 17134117
[TBL] [Abstract][Full Text] [Related]
19. Primary CNS Lymphoma.
Grommes C; DeAngelis LM
J Clin Oncol; 2017 Jul; 35(21):2410-2418. PubMed ID: 28640701
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging in Central Nervous System Lymphoma.
Nabavizadeh SA; Vossough A; Hajmomenian M; Assadsangabi R; Mohan S
Hematol Oncol Clin North Am; 2016 Aug; 30(4):799-821. PubMed ID: 27443998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
